The case for prostate brachytherapy in the affordable care act era

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 3, 2015, Pages 465-467

  Durkee, Ben Y ^a   Buyyounouski, Mark K ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COMPENSATION; EDITORIAL; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MALE; MEDICAL FEE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION ONCOLOGIST; REIMBURSEMENT; AGE; BLOOD; CANCER REGISTRY; COST CONTROL; ECONOMICS; INTENSITY MODULATED RADIATION THERAPY; POPULATION DYNAMICS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

PROSTATE SPECIFIC ANTIGEN;

AGE FACTORS; BRACHYTHERAPY; COST CONTROL; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; PATIENT PROTECTION AND AFFORDABLE CARE ACT; POPULATION DYNAMICS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; SEER PROGRAM; UNITED STATES;

EID: 84923239889     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.10.014     Document Type: Editorial

References (17)

1. A.B. Mariotto, K.R. Yabroff, and Y. Shao Projections of the cost of cancer care in the United States: 2010-2020 J Natl Cancer Inst 103 2011 117 128
2. J.M. Mitchell Urologists' use of intensity-modulated radiation therapy for prostate cancer N Engl J Med 369 2013 1629 1637
3. S.P. Elliott, S.L. Jarosek, and T.J. Wilt Reduction in physician reimbursement and use of hormone therapy in prostate cancer J Natl Cancer Inst 102 2010 1826 1834
4. Congressional Budget Office Technological change and the growth of health care spending 2008 Congressional Budget Office 12 Available at: www.cbo.gov/sites/default/files/cbofiles/ftpdocs/89xx/doc8947/01-31-techhealth.pdf Accessed December 24, 2013
5. P.L. Nguyen, X. Gu, and S.R. Lipsitz Cost implications of the rapid adoption of newer technologies for treating prostate cancer J Clin Oncol 29 2011 1517 1524
6. Elliott SP, Jarosek SL, Virnig BA. Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients. Types of prostate radiation. Data Points # 16 (prepared by the University of Minnesota DEcIDE Center, under Contract No. HHSA29020100013I). Rockville, MD: Agency for Healthcare Research and Quality; November 2012. AHRQ Publication No. 12-EHC095-EF.
7. D. Blumenthal, and S.R. Collins Health care coverage under the Affordable Care Act: A progress report N Engl J Med 371 2014 275 281
8. Congressional Budget Office. Updated estimates of the effects of the insurance coverage provisions of the Affordable Care Act, April 2014: http://www.cbo.gov/publication/45231. Accessed December 24, 2013.
9. American Cancer Society. Cancer Facts & Figures, 2014. American Cancer Society. Atlanta, GA.
10. SEER Cancer Statistics Factsheets: Prostate Cancer 2014 National Cancer Institute Bethesda, MD http://seer.cancer.gov/statfacts/html/prost.html Accessed September 8, 2014
11. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
12. P. Grimm, I. Billiet, and D. Bostwick Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group BJU Int 109 Suppl 1 2012 22 29
13. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916 3922
14. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
15. C. Shah, T.B. Lanni Jr, and M.I. Ghilezan Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer Brachytherapy 11 2012 441 445
16. J.H. Hayes, D.A. Ollendorf, and S.D. Pearson Observation versus initial treatment for men with localized, low-risk prostate cancer: A cost-effectiveness analysis Ann Intern Med 158 2013 853 860
17. D.A. Ollendorf, J. Hayes, and P. McMahon Management options for low-risk prostate cancer: A report on comparative effectiveness and value December 2009 Institute for Clinical and Economic Review Boston, MA Available at: http://www.icer-review.org/index.php/mgmtoptionlrpc.html Accessed December 27, 2013